Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Protocols recommend an initial loading phase of 22.5 mg twice weekly for 46 weeks, followed by a maintenance dose of 22.5 mg every 12 weeks
More healing benefits are being discovered every day
Unknown long-term effects
The compound failed its Phase IIb obesity endpoint in 2007, and Metabolic Pharmaceuticals terminated clinical development the same year
- Muscle Growth & Endurance: Facilitates muscle growth and boosts endurance levels
5Amino1MQ (5Amino1Methylquinolinium) is a novel small molecule derived from quinolinium salts that has been studied for its ability to inhibit NNMT (Nicotinamide NMethyltransferase), an enzyme involved in metabolic dysfunction, obesity, and cellular aging
US$ 29.72
US$ 28.25
US$ 29.82
US$ 22.39
US$ 24.01
US$ 29.12
US$ 20.74
